Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0257 Transporter Info
Gene Name SLC2A2
Transporter Name Glucose transporter type 2, liver
Gene ID
6514
UniProt ID
P11168
Epigenetic Regulations of This DT (EGR)

Methylation

  Type 2 diabetes

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Hypermethylation of SLC2A2 in type 2 diabetes [ 1 ]

Location

 Promoter

Epigenetic Type

 Methylation Experiment Method HumanMethylation450 BeadChip

Related Molecular Changes

 Down regulation of SLC2A2 Experiment Method Microarrays

Studied Phenotype

 Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

 Patient tissue samples

Additional Notes

 SLC2A2 had increased methylation and decreased expression in T2D islets.

  Pancretic ductal adenocarcinoma

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

 5'UTR (cg15212349)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 2.97E+00 Statistic Test p-value: 8.76E-40; Z-score: 1.23E+01

Methylation in Case

 2.08E-01 (Median) Methylation in Control 7.00E-02 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

 5'UTR (cg22146252)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.11E+00 Statistic Test p-value: 7.97E-07; Z-score: 1.40E+00

Methylation in Case

 3.65E-01 (Median) Methylation in Control 3.28E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

 Body (cg17180443)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.34E+00 Statistic Test p-value: 8.07E-11; Z-score: 1.37E+00

Methylation in Case

 2.34E-01 (Median) Methylation in Control 1.74E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC2A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

 Body (cg16338944)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.06E+00 Statistic Test p-value: 5.95E-05; Z-score: 1.05E+00

Methylation in Case

 8.75E-01 (Median) Methylation in Control 8.27E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Prostate cancer

            6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in prostate cancer [ 3 ]

Location

 5'UTR (cg04349243)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 2.80E+00 Statistic Test p-value: 6.28E-03; Z-score: 7.06E+00

Methylation in Case

 5.36E-01 (Median) Methylation in Control 1.91E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in prostate cancer [ 3 ]

Location

 Body (cg22054793)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.10E+00 Statistic Test p-value: 8.20E-04; Z-score: 4.81E+00

Methylation in Case

 9.21E-01 (Median) Methylation in Control 8.37E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in prostate cancer [ 3 ]

Location

 Body (cg11902539)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.03E+00 Statistic Test p-value: 4.28E-03; Z-score: 2.73E+00

Methylation in Case

 9.47E-01 (Median) Methylation in Control 9.19E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC2A2 in prostate cancer [ 3 ]

Location

 Body (cg26548134)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.18E+00 Statistic Test p-value: 8.30E-03; Z-score: -5.69E+00

Methylation in Case

 7.57E-01 (Median) Methylation in Control 8.95E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC2A2 in prostate cancer [ 3 ]

Location

 Body (cg20456136)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.06E+00 Statistic Test p-value: 1.85E-02; Z-score: 2.30E+00

Methylation in Case

 9.37E-01 (Median) Methylation in Control 8.86E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC2A2 in prostate cancer [ 3 ]

Location

 Body (cg07187808)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.08E+00 Statistic Test p-value: 3.52E-02; Z-score: 1.91E+00

Methylation in Case

 6.51E-01 (Median) Methylation in Control 6.03E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Bladder cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in bladder cancer [ 4 ]

Location

 TSS1500 (cg14777768)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.26E+00 Statistic Test p-value: 1.15E-02; Z-score: 2.72E+00

Methylation in Case

 1.59E-01 (Median) Methylation in Control 1.26E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in bladder cancer [ 4 ]

Location

 TSS1500 (cg07139301)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.23E+00 Statistic Test p-value: 1.30E-02; Z-score: 1.64E+00

Methylation in Case

 8.00E-02 (Median) Methylation in Control 6.52E-02 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in bladder cancer [ 4 ]

Location

 TSS1500 (cg01146875)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.08E+00 Statistic Test p-value: 3.32E-02; Z-score: 7.94E-01

Methylation in Case

 1.05E-01 (Median) Methylation in Control 9.78E-02 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC2A2 in bladder cancer [ 4 ]

Location

 TSS1500 (cg24302235)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.19E+00 Statistic Test p-value: 3.61E-02; Z-score: -9.61E-01

Methylation in Case

 8.16E-02 (Median) Methylation in Control 9.70E-02 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC2A2 in bladder cancer [ 4 ]

Location

 TSS200 (cg09710316)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.49E+00 Statistic Test p-value: 6.34E-12; Z-score: -1.43E+01

Methylation in Case

 5.09E-01 (Median) Methylation in Control 7.61E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC2A2 in bladder cancer [ 4 ]

Location

 TSS200 (cg03464896)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.07E+00 Statistic Test p-value: 1.90E-05; Z-score: -1.05E+01

Methylation in Case

 8.03E-01 (Median) Methylation in Control 8.57E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of SLC2A2 in bladder cancer [ 4 ]

Location

 Body (cg07649206)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 4.31E-03; Z-score: -1.04E+00

Methylation in Case

 8.58E-01 (Median) Methylation in Control 8.79E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Breast cancer

            9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 TSS1500 (cg14777768)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 2.65E+00 Statistic Test p-value: 1.72E-19; Z-score: 3.79E+00

Methylation in Case

 4.56E-01 (Median) Methylation in Control 1.72E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 TSS1500 (cg07139301)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 4.22E+00 Statistic Test p-value: 6.09E-17; Z-score: 6.14E+00

Methylation in Case

 3.17E-01 (Median) Methylation in Control 7.51E-02 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 TSS1500 (cg01146875)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 2.30E+00 Statistic Test p-value: 2.37E-15; Z-score: 3.68E+00

Methylation in Case

 3.51E-01 (Median) Methylation in Control 1.52E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 TSS1500 (cg24302235)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.57E+00 Statistic Test p-value: 3.09E-09; Z-score: 1.49E+00

Methylation in Case

 2.99E-01 (Median) Methylation in Control 1.91E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 TSS1500 (cg03699904)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.17E+00 Statistic Test p-value: 3.58E-06; Z-score: 1.50E+00

Methylation in Case

 4.66E-01 (Median) Methylation in Control 3.98E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 TSS200 (cg03464896)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.06E+00 Statistic Test p-value: 1.54E-11; Z-score: -2.29E+00

Methylation in Case

 8.06E-01 (Median) Methylation in Control 8.56E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 TSS200 (cg09710316)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.04E+00 Statistic Test p-value: 9.70E-04; Z-score: -6.62E-01

Methylation in Case

 7.39E-01 (Median) Methylation in Control 7.67E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 8

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 Body (cg07649206)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 6.48E-08; Z-score: -1.93E+00

Methylation in Case

 8.84E-01 (Median) Methylation in Control 9.10E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 9

 Methylation of SLC2A2 in breast cancer [ 5 ]

Location

 Body (cg10029905)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 1.01E-04; Z-score: -9.62E-01

Methylation in Case

 8.62E-01 (Median) Methylation in Control 8.91E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Renal cell carcinoma

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in clear cell renal cell carcinoma [ 6 ]

Location

 TSS1500 (cg24302235)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.07E+00 Statistic Test p-value: 4.18E-02; Z-score: 1.07E-01

Methylation in Case

 4.35E-02 (Median) Methylation in Control 4.07E-02 (Median)

Studied Phenotype

 Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

 Patient tissue samples

  Colorectal cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in colorectal cancer [ 7 ]

Location

 TSS1500 (cg03699904)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.20E+00 Statistic Test p-value: 1.39E-03; Z-score: -1.06E+00

Methylation in Case

 3.64E-01 (Median) Methylation in Control 4.37E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in colorectal cancer [ 7 ]

Location

 TSS1500 (cg14777768)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.68E+00 Statistic Test p-value: 1.66E-03; Z-score: -1.71E+00

Methylation in Case

 1.80E-01 (Median) Methylation in Control 3.02E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in colorectal cancer [ 7 ]

Location

 TSS1500 (cg24302235)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.36E+00 Statistic Test p-value: 1.98E-02; Z-score: -1.01E+00

Methylation in Case

 1.31E-01 (Median) Methylation in Control 1.78E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC2A2 in colorectal cancer [ 7 ]

Location

 TSS1500 (cg01146875)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.35E+00 Statistic Test p-value: 2.62E-02; Z-score: -1.04E+00

Methylation in Case

 1.53E-01 (Median) Methylation in Control 2.07E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC2A2 in colorectal cancer [ 7 ]

Location

 Body (cg10029905)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 6.02E-03; Z-score: -4.62E-01

Methylation in Case

 8.81E-01 (Median) Methylation in Control 8.97E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC2A2 in colorectal cancer [ 7 ]

Location

 3'UTR (cg11417598)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.17E+00 Statistic Test p-value: 1.10E-02; Z-score: 9.57E-01

Methylation in Case

 8.23E-01 (Median) Methylation in Control 7.06E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Hepatocellular carcinoma

            5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in hepatocellular carcinoma [ 8 ]

Location

 TSS1500 (cg03699904)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.39E+00 Statistic Test p-value: 1.41E-06; Z-score: -1.46E+00

Methylation in Case

 2.11E-01 (Median) Methylation in Control 2.93E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in hepatocellular carcinoma [ 8 ]

Location

 TSS200 (cg09710316)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.29E+00 Statistic Test p-value: 1.75E-04; Z-score: -1.20E+00

Methylation in Case

 3.38E-01 (Median) Methylation in Control 4.36E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in hepatocellular carcinoma [ 8 ]

Location

 TSS200 (cg03464896)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.26E+00 Statistic Test p-value: 1.50E-03; Z-score: -1.09E+00

Methylation in Case

 4.24E-01 (Median) Methylation in Control 5.34E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC2A2 in hepatocellular carcinoma [ 8 ]

Location

 Body (cg07649206)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.39E+00 Statistic Test p-value: 4.46E-06; Z-score: -1.60E+00

Methylation in Case

 4.56E-01 (Median) Methylation in Control 6.33E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC2A2 in hepatocellular carcinoma [ 8 ]

Location

 Body (cg10029905)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.22E+00 Statistic Test p-value: 3.49E-04; Z-score: -8.39E-01

Methylation in Case

 4.41E-01 (Median) Methylation in Control 5.38E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  HIV infection

            6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in HIV infection [ 9 ]

Location

 TSS1500 (cg07139301)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.29E+00 Statistic Test p-value: 3.89E-04; Z-score: 1.10E+00

Methylation in Case

 6.35E-02 (Median) Methylation in Control 4.93E-02 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in HIV infection [ 9 ]

Location

 TSS1500 (cg01146875)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.58E+00 Statistic Test p-value: 4.59E-04; Z-score: 1.79E+00

Methylation in Case

 1.30E-01 (Median) Methylation in Control 8.24E-02 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in HIV infection [ 9 ]

Location

 TSS1500 (cg24302235)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.49E+00 Statistic Test p-value: 1.54E-03; Z-score: 1.46E+00

Methylation in Case

 1.16E-01 (Median) Methylation in Control 7.80E-02 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC2A2 in HIV infection [ 9 ]

Location

 TSS1500 (cg14777768)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.52E+00 Statistic Test p-value: 1.64E-03; Z-score: 1.25E+00

Methylation in Case

 1.16E-01 (Median) Methylation in Control 7.64E-02 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC2A2 in HIV infection [ 9 ]

Location

 TSS1500 (cg03699904)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.12E+00 Statistic Test p-value: 1.71E-02; Z-score: 8.32E-01

Methylation in Case

 2.96E-01 (Median) Methylation in Control 2.64E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC2A2 in HIV infection [ 9 ]

Location

 TSS200 (cg03464896)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.02E+00 Statistic Test p-value: 1.57E-03; Z-score: 7.54E-01

Methylation in Case

 8.65E-01 (Median) Methylation in Control 8.49E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Celiac disease

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in celiac disease [ 10 ]

Location

 TSS200 (cg03464896)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.57E+00 Statistic Test p-value: 1.94E-02; Z-score: 9.54E-01

Methylation in Case

 7.52E-01 (Median) Methylation in Control 4.78E-01 (Median)

Studied Phenotype

 Celiac disease [ ICD-11: DA95]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in celiac disease [ 10 ]

Location

 TSS200 (cg09710316)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.95E+00 Statistic Test p-value: 2.74E-02; Z-score: 1.02E+00

Methylation in Case

 5.66E-01 (Median) Methylation in Control 2.90E-01 (Median)

Studied Phenotype

 Celiac disease [ ICD-11: DA95]

Experimental Material

 Patient tissue samples

  Papillary thyroid cancer

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in papillary thyroid cancer [ 11 ]

Location

 TSS200 (cg03464896)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 9.85E-05; Z-score: -7.35E-01

Methylation in Case

 8.99E-01 (Median) Methylation in Control 9.10E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in papillary thyroid cancer [ 11 ]

Location

 TSS200 (cg09710316)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.01E+00 Statistic Test p-value: 4.27E-02; Z-score: 5.69E-01

Methylation in Case

 8.33E-01 (Median) Methylation in Control 8.22E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in papillary thyroid cancer [ 11 ]

Location

 3'UTR (cg11417598)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 3.26E-02; Z-score: -7.17E-01

Methylation in Case

 8.75E-01 (Median) Methylation in Control 8.95E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Atypical teratoid rhabdoid tumor

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in atypical teratoid rhabdoid tumor [ 12 ]

Location

 Body (cg07649206)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.19E+00 Statistic Test p-value: 4.67E-03; Z-score: 4.56E-01

Methylation in Case

 5.70E-02 (Median) Methylation in Control 4.78E-02 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC2A2 in atypical teratoid rhabdoid tumor [ 12 ]

Location

 Body (cg10029905)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.18E+00 Statistic Test p-value: 1.35E-02; Z-score: -7.01E-01

Methylation in Case

 1.28E-01 (Median) Methylation in Control 1.51E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC2A2 in atypical teratoid rhabdoid tumor [ 12 ]

Location

 3'UTR (cg11417598)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.09E+00 Statistic Test p-value: 8.68E-12; Z-score: -2.07E+00

Methylation in Case

 7.93E-01 (Median) Methylation in Control 8.68E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Panic disorder

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC2A2 in panic disorder [ 13 ]

Location

 Body (cg10029905)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.08E+00 Statistic Test p-value: 4.44E-02; Z-score: 2.81E-01

Methylation in Case

 1.50E+00 (Median) Methylation in Control 1.39E+00 (Median)

Studied Phenotype

 Panic disorder [ ICD-11: 6B01]

Experimental Material

 Patient tissue samples

  Gastric cancer

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Moderate/significant hypermethylation of SLC2A2 in gastric cancer than that in healthy individual/adjacent tissue

Studied Phenotype

 Gastric cancer [ICD-11:2B72]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 2.00E-05; Fold-change: -0.245146692; Z-score: -1.481495252

The Methylation Level of Disease Section Compare with the Adjacent Tissue

 p-value: 3.93E-20; Fold-change: -0.343478638; Z-score: -26.10090599
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data of patients in the normal section of the tissue adjacent to the disease section
Download DT methylation data in the tissue of healthy individual

  Multilayered rosettes embryonal tumour

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Significant hypomethylation of SLC2A2 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

 Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 3.16E-23; Fold-change: -0.357977693; Z-score: -9.881453275
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data in the tissue of healthy individual

Histone acetylation

  High concentrations of glucose

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Hyperacetylation of Slc2a2 in high concentrations of glucose (compare with low concentrations of glucose counterpart cells) [ 14 ]

Location

 Promoter

Epigenetic Type

 Histone acetylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

 Up regulation of Slc2a2 Experiment Method RT-qPCR

Studied Phenotype

 High concentrations of glucose

Experimental Material

 Mouse insulinoma 6 cells

Additional Notes

 High levels of glucose (30 mM) cause hyperacetylation of histone H4 at both insulin and Slc2a2 gene promoters in MIN6 cells.

  Type 2 diabetes

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Hypoacetylation of SLC2A2 in type 2 diabetes (compare with counterpart normal rat cells) [ 15 ]

Location

 Promoter

Epigenetic Type

 Histone acetylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

 Down regulation of SLC2A2 Experiment Method RT-qPCR

Studied Phenotype

 Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

 Model organism in vivo (mouse)

Additional Notes

 Decreased H3 acetylation basically was correlated with decreased Glut2 gene expression.

Histone dimethylation

  Type 2 diabetes

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Higher level of histone dimethylation of SLC2A2 in type 2 diabetes (compare with counterpart normal rat cells) [ 15 ]

Location

 Promoter

Epigenetic Type

 Histone dimethylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

 Down regulation of SLC2A2 Experiment Method RT-qPCR

Studied Phenotype

 Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

 Model organism in vivo (mouse)

Additional Notes

 Increased H3K9me2 levels basically was correlated with decreased Glut2 gene expression.

Histone monomethylation

  Type 2 diabetes

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Higher level of histone monomethylation of SLC2A2 in type 2 diabetes (compare with counterpart normal rat cells) [ 15 ]

Location

 Promoter

Epigenetic Type

 Histone monomethylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

 Down regulation of SLC2A2 Experiment Method RT-qPCR

Studied Phenotype

 Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

 Model organism in vivo (mouse)

Additional Notes

 Increased H3K4me levels basically was correlated with decreased Glut2 gene expression.
References
1 Whole-Genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes Pathogenesis. Diabetes. 2017 Apr;66(4):1074-1085.
2 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
3 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
4 DNA Methylation Dynamics in Urological Tumors.
5 Genome-wide Scan for Methylation Profiles in Breast Cancer
6 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
7 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
8 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
9 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
10 The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Mol Ther Oncolytics. 2019 Feb 5;12:235-245.
11 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
12 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
13 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
14 Glucose regulates insulin gene transcription by hyperacetylation of histone h4. J Biol Chem. 2003 May 30;278(22):19660-6.
15 Liver histone H3 methylation and acetylation may associate with type 2 diabetes development. J Physiol Biochem. 2015 Mar;71(1):89-98.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.